2-(2-methyl-1-(4-(methylsulfonyl)benzyl)-1H-indol-3-yl)acetic acid

ID: ALA4094939

PubChem CID: 57740764

Max Phase: Preclinical

Molecular Formula: C19H19NO4S

Molecular Weight: 357.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(CC(=O)O)c2ccccc2n1Cc1ccc(S(C)(=O)=O)cc1

Standard InChI:  InChI=1S/C19H19NO4S/c1-13-17(11-19(21)22)16-5-3-4-6-18(16)20(13)12-14-7-9-15(10-8-14)25(2,23)24/h3-10H,11-12H2,1-2H3,(H,21,22)

Standard InChI Key:  SPFNZISNUPAYKM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    7.0163  -14.5939    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6118  -13.8881    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.2029  -14.5913    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7815  -11.4456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4425  -10.9649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1874  -10.1859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2201  -11.2163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6649   -9.5227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4780   -9.6046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9554   -8.9414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8135  -10.3497    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7829  -12.2628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4912  -12.6702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4890  -13.4847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1965  -13.8921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9046  -13.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9006  -12.6609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1925  -12.2572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3200  -13.4781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1191  -10.9671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3719  -10.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8293   -9.5906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0338   -9.7590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7838  -10.5363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3281  -11.1364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
 20  4  1  0
  4  5  1  0
  5  6  2  0
  6 21  1  0
  5  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  4 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16  2  1  0
  2 19  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
M  END

Associated Targets(Human)

PTGDR2 Tchem G protein-coupled receptor 44 (4688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 357.43Molecular Weight (Monoisotopic): 357.1035AlogP: 3.03#Rotatable Bonds: 5
Polar Surface Area: 76.37Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.30CX Basic pKa: CX LogP: 2.70CX LogD: -0.26
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -1.11

References

1. Sandham DA, Barker L, Brown L, Brown Z, Budd D, Charlton SJ, Chatterjee D, Cox B, Dubois G, Duggan N, Hall E, Hatto J, Maas J, Manini J, Profit R, Riddy D, Ritchie C, Sohal B, Shaw D, Stringer R, Sykes DA, Thomas M, Turner KL, Watson SJ, West R, Willard E, Williams G, Willis J..  (2017)  Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma.,  (5): [PMID:28523115] [10.1021/acsmedchemlett.7b00157]

Source